entertainment -WSS

entertainment

author：leisure time 2025-08-17 03:37:39 - browse：465

Fiona Marshall, president of the Novartis research hub in Cambridge, Mass., speaks Thursday during the STAT Future Summit. STAT

Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy.

The hub, which is headquartered in Cambridge, Mass., and for years has been known as Novartis Institutes for BioMedical Research, or NIBR, will soon simply be known as Novartis Biomedical Research.

But that’s not the only thing that’s changing, Fiona Marshall, the hub’s president, told a virtual audience Thursday during the 2023 STAT Future Summit. The new name reflects a larger shift by the pharma giant to retool its research strategy — from one driven by the pure pursuit of scientific discovery to a tighter focus on projects likely to yield commercially successful drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

WSS

Cytokinetics CEO stresses company can launch heart drug on its own

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Questions and answers about ramping up H5N1 bird flu vaccine

Glen Campbell's doctor discusses his public struggle with Alzheimer's

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Study finds gene variants tied to breast cancer risk in Black women

entertainment

entertainment

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Medical leaders decry Supreme Court decision on affirmative action

Venture capitalist Bob Kocher on the state of digital health

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

New air purifier tech could be key to improving indoor air quality

Reports of telehealth's death have been greatly exaggerated

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

focus

ASCO eve: Let’s set the table for this year's meeting

Case highlights the risks of experimental stem cell therapy

Helping hospitals and community health centers plan for resilience

Cytokinetics CEO stresses company can launch heart drug on its own

Case highlights the risks of experimental stem cell therapy

Citing H5N1 threat, CDC urges peak flu monitoring this summer

hotspot

entertainment

focus

knowledge